"The Times They Are a-Changin'": Addressing Common Misconceptions About the Role of Safe Supply in North America's Overdose Crisis.

Competing Interests: Matthew Bonn reports personal fees from AbbVie, a pharmaceutical research and development company, and grants and personal fees from Gilead Sciences, a research-based biopharmaceutical company, outside of the submitted work. Sofia Bartlett has participated in Advisory Board Programs and received speakers’ honoraria from Gilead Sciences, outside of the submitted work (all personal fees given as unrestricted donations to the British Columbia Centre for Disease Control Foundation for Public Health). The other authors have no conflicts to declare.